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Numerous studies have indicated an increased risk of vascular disease among migraineurs. Alterations in
endothelial and arterial function, which predispose to atherosclerosis and cardiovascular diseases, have been
suggested as an important link between migraine and vascular disease. However, the available evidence is
inconsistent. We aimed to review and summarize the published evidence about the peripheral vascular
dysfunction of migraineurs.
We systematically searched in BIOSIS, the Cochrane database, Embase, Google scholar, ISI Web of Science, and
Medline to identify articles, published up to April 2013, evaluating the endothelial and arterial function of
migraineurs.
Several lines of evidence for vascular dysfunction were reported in migraineurs. Findings regarding
endothelial function are particularly controversial since studies variously indicated the presence of
endothelial dysfunction in migraineurs, the absence of any difference in endothelial function between
migraineurs and non-migraineurs, and even an enhanced endothelial function in migraineurs. Reports
on arterial function are more consistent and suggest that functional properties of large arteries are
altered in migraineurs.
Peripheral vascular function, particularly arterial function, is a promising non-invasive indicator of the
vascular health of subjects with migraine. However, further targeted research is needed to understand
whether altered arterial function explains the increased risk of vascular disease among patients
with migraine.
Keywords: Migraine; Migraine with aura; Arterial stiffness; Endothelial function; Flow mediated dilation;
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Risk factorsIntroduction
Numerous studies have indicated that migraineurs have
an increased risk of vascular diseases. The association
between migraine and ischemic stroke was the earliest
to be recognized [1-3]. Thereafter, migraine has been
associated also with myocardial infarction, hemorrhagic
stroke, retinal vasculopathy, cardiovascular mortality,
incidental brain lesions, including infarct-like lesions,
and in some instances also with peripheral artery disease
(Table 1) [4-7]. Mechanisms which may explain these* Correspondence: simona.sacco@yahoo.com
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in any medium, provided the original work is passociations have been discussed previously [5,8-10]. One
of the plausible mechanisms predisposing individuals to
atherosclerosis and vascular diseases is endothelial and
arterial dysfunction [11]. Consequently, several studies
have evaluated the vascular function of migraineurs out-
side the brain, providing equivocal results. The aim of
the present study was to review the published evidence
linking peripheral arterial function with migraine.Background information about arterial and endothelial
function and its measurements
The endothelium, i.e. the inner layer of cells of blood
vessels, has physiologically favorable and atheroprotectiven Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Table 1 Evidence referring to the association between
migraine and the risk of vascular disease
Ischemic stroke
Numerous studies demonstrating an association with any
migraine [e1-e22];
Definite association with migraine with aura
[e1,e3-e4,e7-e8,e11-e12,e15-e16,e19-e21];
No definite association with migraine without aura
[e1,e3,e7,e11-e12,e16,e19-e20];
Association with migraine with aura confirmed by three
meta-analyses [e23-e25].
Transient ischemic attack
The risk seems to be increased in migraineurs, although
this issue has not been extensively investigated due to a
challenging overlap of symptoms with migraine aura [e6,e19].
Hemorrhagic stroke
Several studies addressing the topic and providing
inconsistent results [e5,e8-e10,e26-e29];
A meta-analysis of those studies indicating a small but
significant association [e30];
No definite conclusion regarding migraine type.
Cardiac events
Two large studies indicating an association with any
migraine in men and women and with migraine with aura
in women (data not available for men) [e1,e2]; Conflicting
results provided by other available studies [e4,e31-e33];
No association with any migraine in meta-analysis of data
but few studies available [e23]; No analysis according to
migraine type due to lack of data.
A recent study reporting an association between migraine
(any migraine, migraine with aura and migraine without aura)
and myocardial infarction [e4].
Vascular death
A meta-analysis and a large study supporting an association
with migraine with aura [e23];
No association with any migraine according to meta-analysis
of data [e23].
Other vascular diseases
Studies indicating a possible association with any migraine and
retinal disease [e34,e35] and peripheral artery disease [e36-e37].
Brain lesions
Migraine has been associated with white-matter hyperintensities
and infarct-like lesions [e38-e42];
Association of migraine with white matter hyperintensities
confirmed in two meta-analyses [e41,e43]; no definite
association with infarct-like lesions [e43]
References are listed in Additional file 1.
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and responds to each physical or chemical stimulus with
the release of substances, including nitric oxide (NO), with
which the endothelium maintains vasomotor balance and
vascular-tissue homeostasis [13]. The established cardio-
vascular risk factors cause oxidative stress initiating a
chronic inflammatory process which alters the endothelialcells capacity. This leads to “endothelial dysfunction” with
a reduction in endothelium-dependent vasodilation and
the induction of a specific state of “endothelial activation,”
characterized by a proinflammatory, proliferative, and
procoagulatory milieu which favors all stages of athero-
genesis, pathological inflammatory processes, and vascular
disease [14]. Endothelial dysfunction represents an early
step in the development of atherosclerosis [15]. Endothelial
function can be investigated by invasive and non-invasive
tests [16]. Invasive tests are based upon intra-arterial infu-
sion of vasoactive agents. Among the several non-invasive
methods of measuring endothelial function, flow-mediated
dilation (FMD), laser Doppler flowmetry, and digital pulse
amplitude tonometry (PAT) are the most widely adopted
[16-18]. Figure 1 shows details about measurement of
FMD [16-19].
Measures of arterial elasticity are also being investi-
gated as non-invasive means of gauging vascular health
[14]; the most commonly considered parameters are
pulse wave velocity (PWV), augmentation index (AIx)
and local arterial distensibility in the carotid artery or
in the aorta. While FMD addresses functional status of
the endothelium, PWV, AI, and local arterial distensi-
bility are better related to structural changes in the
vessel wall. PWV is an indicator of segmental arterial
stiffness. Carotid-femoral PWV is the gold standard of
assessment (Figure 2), but it is difficult to measure, so
in clinical practice it can be replaced by the measurement
of brachial-ankle PWV (although this measurement in-
cludes some muscular arteries and not only the elastic
ones). The AIx (Figure 3) is an index related to the
stiffness of the systemic arterial tree. An increase in
arterial stiffness leads to a more proximal point of
reflection, thus altering the wave profile as measured
by the instruments. Local arterial distensibility is assessed
by measuring the minimum and maximum diameter of
central arteries – such as the carotid artery or aorta –
by ultrasound or MRI with simultaneous recording of
the blood pressure in the arterial district from which the
diameters are obtained.Search strategy and selection criteria
Data for this review were obtained through searches in
BIOSIS, the Cochrane database, Embase, Google scholar,
ISI Web of Science, and Medline from their first availabil-
ity up to April 2013. The search terms included “migraine”
OR “headache” AND (“endothelial function”, “endothelial
injury”, “arterial stiffness”, “arterial distensibility”, “vascular
resistance”, “vascular reactivity”, “flow-mediated dilation”,
“forearm blood flow”, “arterial pulse wave velocity”, “aug-
mentation index”). We also searched reference lists of
identified articles and papers quoting identified articles.
We reviewed only studies published in English.
Figure 1 Flow-mediated dilation. Flow-mediated dilation (FMD) measures endothelial function by inducing a temporary ischemia in a
brachial artery and observing the amount of vasodilation following the stressor event. After a baseline measurement of the artery diameter
via an ultrasound probe, a sphygmomanometer blood pressure cuff is positioned on the right forearm 2 cm below the elbow and inflated
to 250 mmHg to produce ischemia in the forearm. The cuff is deflated after some minutes, usually 5, thus causing a reactive hyperemia
which in turn produces a shear stress stimulus that induces the endothelium to release nitric oxide as a vasodilator. FMD is considered as
diameter after reactive hyperemia - basal diameter/basal diameter × 100. The figure shows the diameter (upper part) and shear rate (lower
part) of brachial artery during FMD before (grey-shaded part on the left), during (black-shaded part), and after (grey-shaded part on the
right) ischemia.
Figure 2 Carotid-Femoral Pulse Wave Velocity. Increased arterial stiffness leads to increased velocity of the pulse wave generated in the
arteries by the contraction of the left ventricle. Pulse wave velocity (PWV) consists in measuring pulse wave profiles by tonometry at two distant
locations (carotid and femoral) and measuring the delay in the onset of the wave between those two locations. PWV is calculated as the distance
traveled by the wave divided by the time taken to travel that distance. Surface distance between the two recording sites and simultaneously
recorded electrocardiograms are used to calculate wave transit time. The figure shows tonometric (white lines) recordings of the carotid (above)
and femoral (below) artery waves according with simultaneous electrocardiographic (yellow lines) ‘R’ wave of the electrocardiogram as a
timing reference.
Sacco et al. The Journal of Headache and Pain 2013, 14:80 Page 3 of 10
http://www.thejournalofheadacheandpain.com/content/14/1/80
Figure 3 Augmentation Index. The interaction between the
incident pulse wave and the reflected pulse wave, which is
generated by the arterial resistance, is expressed by the
augmentation index, which is the amount of pulse wave induced
only by arterial resistance. In the figure, the upper arrow indicates
the first systolic peak (incident wave), while the lower arrow
indicates the second systolic peak (reflected wave). The ratio
between the reflected wave/incident wave × 100 is the
augmentation index.
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Arterial and endothelial function in migraineurs
Several lines of evidence for vascular dysfunction have been
identified in migraineurs and there is increasing evidence to
suggest that in migraineurs the vascular system is impaired
not only within the brain.Endothelial function in migraineurs
The many studies assessing endothelial function in
migraineurs have used heterogeneous techniques and
indicators as shown in Tables 2, 3 and 4. Most of them
assessed endothelial function by measuring FMD
(Table 2) [20-30], some used PAT (Table 3) [31,32],
some measured peripheral vasodilation in response
to pharmacological stimuli (Table 3) [20,30,33-35], and
others assessed endothelial progenitor cells (EPCs)
(Table 4) [23,36,37]. Findings were not consistent
across the studies. Several among the available studies
did not reveal any alteration in the endothelial function
of migraineurs. Six of them did not find any difference
in FMD between migraineurs and control subjects
(Table 2) [20-23,25,26] and a further study confirmed
the lack of any alteration in endothelial function
assessed by PAT ratio (Table 3) [32]. Three studies
assessing peripheral vasodilation after pharmacological
stimuli found comparable responses in subjects withand without migraine (Table 3) [20,33,35]. However,
other studies supported the presence of endothelial
dysfunction in migraineurs. Four studies reported de-
creased FMD in migraineurs [24,27,29,30]; in one of
those studies, FMD correlated with dysfunction of the
autonomic nervous system (Table 2) [24]. Another
study, using PAT, reported that subjects with chronic
migraine had worse endothelial function (Table 3) [31].
A further study found an abnormal vascular response
to dilating pharmacological stimuli (Table 3) [34]. The
possible underlying mechanisms of endothelial dys-
function in those studies were unclear. Since the im-
pairment of FMD was demonstrated also in individuals
with recent onset of migraine it is unlikely that the dis-
turbance was a consequence of longstanding and re-
peated exposure to the vasoconstrictor agents used for
migraine treatment [27]. In addition, the results of one
study suggested that the impaired vascular reactivity
in migraineurs is entirely attributable to a reduced
response of vascular smooth muscle cells to NO while
the endothelial response to NO appeared intact [34].
Some additional studies supported the presence of
an endothelial dysfunction in migraineurs by docu-
menting a decreased number of EPCs [23,36] or a
higher number of more mature EPCs (which could
be associated with potential endothelial damage) in
migraineurs (Table 4) [37]. EPCs maintain the integ-
rity of damaged endothelium and are considered a
marker of endothelial function [38]. At variance with
other studies, Vernieri et al., found that subjects
with migraine with aura had higher FMD than both
control subjects and migraine without aura subjects
indicating an excessive arterial response to hyperemia.
It is suggested that this is probably an effect of an
increased sensitivity to endothelium-derived NO or of
increased release of NO induced by shear stress (Table 2)
[28]. In agreement, Yetkin et al., found that migraineurs
have an increased nitrate-mediated response showing
a major role of NO supersensitivity in migraine patho-
physiology (Table 3) [30].
Several studies support the presence of biochemical
changes in the endothelial activation of migraineurs.
These biochemical changes may precede structural
damage. In particular, alterations in the NO pathway
have been described [30,39,40] as well as increased
levels of calcitonin gene-related peptide (CGRP), vascu-
lar endothelial growth factors (VEGF), von Willebrand
factor (vWF) activity, tissue plasminogen activator anti-
gen, C-reactive protein and endothelin-1 [21,23,40]. Re-
cently, a study involving 40 non-hypertensive subjects
with migraine without aura randomized to treatment
with enalapril 5 mg twice a day for 3 months or to pla-
cebo, showed that active treatment was associated with
an increase in FMD values [41].














De Hoon, 2006 [20] CC Migraine: 10 60 CVD, HYP, DM, dyslipidemia, CS ICHD-I No differences in FMD
between migraineurs
and controlsControls: 10
Hamed, 2010 [21] CC Migraine: 38 89 CVD and vascular RF, DM, CS,
alcoholism, active gastrointestinal
disease, gout, epilepsy, recent
infection, renal failure, pregnancy
or lactation, regular use FANS or
antimigrainous drugs and OC





Perko, 2011 [22] CC MwA: 20 80 CVD, obesity, HYP, dyslipidemia,
pregnancy or lactation and regular
use of vasoactive drugs




Rodriguez-Osorio, 2012 [23] CC Migraine : 47 98 CAD, inflammatory disease, obesity,
HYP, DM, dyslipidemia, CS, infectious
disease, severe systemic disease,
ovarium pathology, pregnancy or
lactation, use of vasoactive drugs





Rossato, 2011 [24] CC Migraine: 20 75 Age ≥50, vascular RF, CS, use of
vasoactive drugs
Not reported Decreased FMD in
migraineurs
Controls: 20
Silva, 2007 [25] CC Migraine: 50
(MwA: 25; MwoA: 25)




Thomsen, 1996 [26] CC MwoA: 12 100 Use of any daily drugs ICHD-I No differences in FMD
between migraineurs
and controlsControls: 12
Vanmolkot, 2007 [27] CC Migraine: 50 78 Age >50, CVD, HYP, obesity, DM,
dyslipidemia, pregnancy or lactation,






Vernieri, 2010 [28] CC Migraine:21 None ICHD-II FMD increased from
controls to MwoA to
MwA patients(MwA: 11; MwoA: 10)
Controls: 13
Yetkin, 2006 [29] CC Migraine: 45 80 CAD, HYP, obesity, DM, infectious
disease, ovarium pathology
ICHD-I Decreased FMD in
migraineurs
Controls: 45
Yetkin, 2007 [30] CC Migraine: 24 89 HYP, CAD, DM, infectious disease ICHD-I Decreased FMD in
migraineurs
Controls: 26
CC case–control; MwA migraine with aura; MwoA migraine without aura; CVD cardiovascular disease; HYP arterial hypertension; DM diabetes mellitus; CS cigarette
smoking; RF risk factors; FANS non steroid anti-inflammatory drugs; OC oral contraceptives; CAD coronary artery disease; ICHD International classification headache
disorders; FMD flow-mediated dilation.
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Compared with studies on endothelial function, reports
on arterial function measured with PWV, AIx, and local
arterial distensibility are more consistent and suggest
that functional properties of large arteries are altered in
migraineurs [27,42-46] (Table 5).
Four studies addressed PWV in migraineurs (Table 5)
[27,42-44]. Ikeda et al. evaluated peripheral PWV [42]
while the other authors assessed central PWV [27,43,44].
Three studies on PWV [27,42,43] found higher values
of this parameter in migraineurs with respect to non-
migraineurs. However, in one of the studies PWV didnot correlate with the presence of migraine after ad-
justment for age and mean arterial pressure [27]. The
inclusion in the study of patients with a short history
of migraine and with less use of vasoconstrictive agents
may explain the difference [27]. Schillaci et al., also
addressed PWV according to migraine type and reported
that subjects with migraine either with or without aura
had increased PWV with respect to controls while mi-
graine with aura subjects had higher aortic PWV than
those without aura [43]. A more recent population-
based study, involving a larger number of migraineurs,
has challenged the suggestion of possible impairment
















Jiménez-Caballero, 2013 [31] CC CM: 21 71 Age ≥50, CVD, inflammatory




regular use of vasoactive
drugs
ICHD-II Smaller RHI in migraineurs
Controls: 21
Liman, 2012 [32] CC MwA: 29 100 CVD, obesity, HYP, DM,
pregnancy, use of drugs
(statins, anticoagulants or
antiplatelet and intake of
triptans within the
previous 24 h)
ICHD-II No differences in PAT ratio
between migraineurs
and controlsControls: 30
Vasodilation in response to pharmacological stimuli
De Hoon, 2006 [20] CC Migraine: 10 60 CVD, HYP, DM,
dyslipidemia, CS
ICHD-I No differences between





Edvinsson, 2008 [33] CC MwoA: 9 78 None ICHD-I No differences between
migraineurs and controls in
vasodilation response after
local heating and iontophoretic
administration of acetylcholine,
sodium nitroprusside, and CGRP
Controls: 9
Napoli, 2009 [34] CC MwoA: 12 58 HYP, DM,
hypercholesterolemia,
CVD, CS
ICHD-I Reduced response to
endothelium-dependent
vasodilation and production
of cGMP in migraineurs; no
difference in production of NO
Controls: 12
Vanmolkot, 2010 [35] CC Migraine:16 75 Age >50, CVD, HYP,
obesity, DM, CS,
dyslipidemia, pregnancy
or lactation, use of
vasoactive drugs
(except OC)
ICHD-II No differences between




Yetkin, 2007 [30] CC Migraine: 24 89 HYP, CAD, DM,
infectious disease
ICHD-I Higher nitrate-mediated dilation
in migraineurs
Controls: 26
CC case–control; CM chronic migraine; MwA migraine with aura; MwoA migraine without aura; CVD cardiovascular disease; HYP arterial hypertension; DM,diabtes
mellitus; CS cigarette smoking; OC oral contraceptive; ICHD International classification headache disorders; RHI reactive hyperhemia index; PAT peripheral arterial
tonometry; CGRP Calcitonin Gene Related Peptide; cGMP cyclic guanosine monophosphate; NO nitric oxide.
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et al. reported no differences in PWV among subjects
with migraine with aura, migraine without aura, and
controls [44]. In this latter study subjects with known
cardiovascular risk factors were included and this may
explain the differences in the results [44].
Higher values of AIx were found in migraineurs by five
studies [27,31,32,43,45], which variously measured AIx
in the radial artery [45], in the aorta [27,43] or by finger
tonometry [31,32]. One of those studies involved only
women with migraine with aura [32] and one involved
only subjects with chronic migraine [31]. Schillaci et al.reported increased AI in migraine with and without aura
with respect to controls and no differences between the
two groups of migraineurs [43]. All the studies about
AIx had a case–control design, except for a population-
based one [45] which involved cases and controls older
than those of the other studies.
Two studies assessed static arterial parameters [27,46].
De Hoon et al. found that migraineurs had larger tem-
poral artery diameter compared with control subjects
but a decreased distensibility and buffering capacity of
the brachial artery in the absence of significant alter-
ations in the common carotid and femoral arteries














Lee, 2008 [36] CC Migraine: 92 70 CVD, diabetic retinopathy ICHD-II Decreased number and migratory
capacity and higher senescence
levels of endothelial progenitor
cells in migraineurs versus
controls
(MwoA: 67; MwA: 25)
Controls: 37
Oterino, 2013 [37] CC CM: 51 73 CVD, inflammatory disease,
cancer or treatment with
antimitogen agents, pregnancy
in the last year




Rodriguez-Osorio, 2012 [23] CC Migraine : 47 98 CAD, inflammatory disease,
obesity, HYP, DM, dyslipidemia,
CS, infectious disease, severe
systemic disease; ovarium
pathology, pregnancy or
lactation, use of vasoactive
drugs




CC case–control; CM chronic migraine; EM episodic migraine; MwA migraine with aura; MwoA migraine without aura; CVD cardiovascular disease;
CAD coronary artery disease; HYP arterial hypertension; DM diabetes mellitus; CS cigarette smoking; ICHD International classification
headache disorders.
Sacco et al. The Journal of Headache and Pain 2013, 14:80 Page 7 of 10
http://www.thejournalofheadacheandpain.com/content/14/1/80[46]. Vanmolkot et al. found that migraineurs had a de-
creased diameter and compliance of superficial muscular
arteries [27].Discussion
The results of the systematic review suggest the presence
of a peripheral vascular dysfunction in migraineurs.
However, while several studies support an alteration of
arterial function among subjects with migraine, findings
on the endothelial function are less clear.
Endothelial function in migraineurs has sometimes
been reported as impaired and sometimes as altered,
while some studies found no difference compared with
endothelial function in controls. Differences among avail-
able studies may be explained by various inclusion/
exclusion criteria and the generally small number of
participants. Migraine, and particularly migraine with
aura, has been associated with an elevated cardiovascu-
lar profile. The exclusion of subjects with cardiovascular
risk factors from some of the studies may at least partly
explain the described differences. Duration of migraine,
severity of attacks and the active or inactive state of the
disease may also have played a role in the between-
study differences in results. To clarify the status of
endothelial function in migraineurs further, studies are
required that need to involve large number of subjects
of properly selected individuals, applying rigorous
inclusion and exclusion criteria, and including subjects
with a wide range of migraine conditions in terms of
frequency, duration, and severity of the attacks. In
addition, further studies should also adopt a standard-
ized and reliable methodology to address endothelial
function.Regarding arterial function, most of the available evi-
dence supports greater stiffness or impaired compliance
of the arterial system in migraineurs. The mechanisms
underlying the association between migraine and altered
arterial function are likely to be complex and may
involve both structural and functional changes in the
arterial wall. Since all the studies had a cross-sectional
design, a cause-effect relationship between migraine and
increased arterial stiffness cannot be established. How-
ever, migraine usually starts in early adulthood, at an age
in which arterial wall pathologies are rare. In the general
population alteration in arterial function has been asso-
ciated with the presence of vascular risk factors and
is considered a marker of vascular disease associated
with risk of future vascular events [47,48]. Since
most studies addressing arterial function in migraineurs
excluded subjects with comorbid vascular risk factors,
other mechanisms can be hypothesized. The possible
hypotheses include alterations in vessel wall structure in
migraineurs as supported by the presence of impaired
serum elastase activity [49], higher sympathetic tone
[50,51], use of drugs such as triptans and ergot deriva-
tives, or it may represent a primary alteration linked to
the presence of migraine itself [52]. At the moment it is
unknown whether the duration of migraine and the
frequency and severity of the attacks has an impact on
arterial stiffness. Moreover, gender differences may also
play a role in determining arterial stiffness in migraineurs
with females being more susceptible to changes [43].
In addition, possible clinical implications of arterial
dysfunction in migraineurs have to be clarified. In the
general population, arterial dysfunction has been linked to
an increased risk of vascular disease through an athero-
thrombotic mechanism [47,48]. However, in migraineurs


















CC MwA: 11 76 CVD, inflammatory
disease, HYP, DM,
dyslipidemia





distension of brachial artery
and larger right temporal
artery diameter in
migraineurs; no differences













ICHD-II Radial AIx Higher AIx in migraineurs
Controls: 21
Liman, 2012 [32] CC MwA: 29 100 CVD, obesity,
arterial HYP, DM
ICHD-II Peripheral AIx Higher Aix in migraineurs
Controls: 30
Nagai, 2007 [45] PB Group A:134 93 Stroke Validated
questionnaire




Schillaci, 2010 [43] CC MwA:17 85 CVD, inflammatory
disease, HYP, DM,
dyslipidemia
ICHD-II Aortic PWV and
aortic AIx












CC Migraine: 50 78 None ICHD-I Diameter and compliance
parameters of brachial and




and smaller femoral artery
diameter in migraineurs;




for age and mean arterial
pressure
Controls: 50
CC case–control; PB population-based; CM chronic migraine; MwA, migraine with aura; MwoA, migraine without aura; CVD, cardiovascular disease; HYP, arterial
hypertension; DM, diabetes mellitus; RF, risk factors; ICHD, International classification headache disorders; AIx, augmentation index; PWV, pulse wave velocity.
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to vascular events is not supported and much evidence
points against this possibility. [53,54] In fact, intima-media
thickness (IMT), which is a surrogate marker of subclinical
atherosclerosis has not been consistently linked to migraine
status [20,24,27,55,56]. In addition, despite little informa-
tion being available on the frequency of the different sub-
types of ischemic stroke in migraineurs, the available
studies do not support an increased atherosclerotic load
[57,58]. Also the cardiac events observed in migraineurs
did not seem to be attributable to atherothrombosis and
alternative mechanisms have been hypothesized [59-61].
Future studies should also clarify whether the vasculardysfunction may represent a marker able to identify those
migraineurs who are at higher risk of presenting vascular
events and who might be the target of possible preventive
strategies.Conclusion
The study of systemic vascular function is a promising
tool for non-invasively investigating the vascular health
of subjects with migraine. At the moment, evidence is too
scarce to support the clinical application of the techniques
and further research studies are needed to better clarify all
the pending issues.
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